Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GR1802 Extension Study in Chronic Rhinosinusitis With Nasal Polyps
NCT06015243Phase 2Unknown
- Sponsor
- Zhixiang Jintai
- Start
- Aug 2023
- Primary completion
- Dec 2024
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 2 trial of telikibart in chronic rhinosinusitis with nasal polyps (CRSwNP), sponsored by Zhixiang Jintai. Status: unknown.
02
Drugs
telikibart
03
Conditions
chronic rhinosinusitis with nasal polyps (CRSwNP)
Beyond the preview
Go deeper on NCT06015243.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06015243.